Intact Vascular CEO and leadership

Bruce Shook is a medical device executive with more than 30 years of industry experience, including multiple early stage ventures focused on opportunities in cardiac surgery, cardiology, neurosurgery, psychiatry and vascular disease. He serves as Director, President and CEO for both Intact Vascular and Vesper Medical. Intact Vascular is a privately held medical technology company that develops and commercializes vascular scaffolding technology for the treatment of peripheral arterial disease. The company is currently marketing the Tack Endovascular System® in the U.S. and Europe. Vesper Medical was spun out of Intact Vascular in late 2016 and is developing a novel family of venous stents designed to treat deep venous disease.

Prior to Intact Vascular and Vesper Medical, Mr. Shook was co-founder, Director, President and CEO of Neuronetics, Inc., [NASDAQ: STIM] a publicly traded device company that markets a non-invasive brain stimulation technology for the treatment of depression.

Previously, Mr. Shook was co-founder, Director, President and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders, and President of Abiomed [NASDAQ: ABMD], where he obtained PMA approval for the first FDA-approved ventricular assist device. Mr. Shook also developed cardiac pacing and anti-arrhythmia products at Cordis Corporation.

Mr. Shook holds advanced degrees in Biomedical Engineering and Business Administration from Columbia University and the MIT Sloan School of Management, respectively. He earned a B.S. degree in Chemical Engineering from Penn State University. Mr. Shook currently serves on the Board of Directors at Neuronetics, Venarum Medical, the Penn State Research Foundation (Vice Chairman) and Life Sciences Pennsylvania (Medical Technology Committee Chairman). He previously served on the Board of Directors at Surgiquest, Respicardia and CoTherix.

Robert Giasolli is a co-founder of Cagent Vascular serving as the Vice President of Research and Development and is the lead inventor of the Serranator Serration Balloon Catheter. Previously, Mr. Giasolli was a co-founder, inventor and VP of Research and Development of Intact Vascular. Robert was the chief designer for the Tack Endovascular System™. Mr. Giasolli has extensive experience in Intellectual Property strategy and claim development. Formerly, Mr. Giasolli served as a micro system technology executive with extensive experience in design and development of innovative devices. Mr. Giasolli has a strong scientific and business knowledge enabling quick and innovative approach to business development. He has served as a consultant for Smith & Nephew, TSMC, the US Army and Air Force, Sandia National Labs. He has built and outfitted two clean rooms and two metrology labs and has taught technicians and engineers proper use and control of the facilities. He has a BS in Physics from University of Texas at El Paso and an MS in Micro and Nano Manufacturing Systems Engineering from Louisiana Tech, Ruston, LA.

Peter Schneider is a Board Certified Vascular Surgeon who currently practices at Kaiser Permanente Clinic in Honolulu, Hawaii. He is a graduate of Johns Hopkins University School of Medicine. Dr. Schneider is an early adopter of endovascular techniques and has authored multiple scientific publications and books including Endovascular Skills (third edition textbook on endovascular techniques used by fellows and practitioners), Critical Limb Ischemia and Carotid Interventions. Dr. Schneider is also a frequent invited guest lecturer at national and international conferences. He is the Co-Principal Investigator (PI) of Medtronic’s IN.Pact US drug coated balloon trial. He also served as the PI in a carotid stent trial sponsored by WL Gore. Dr. Schneider is an advisor to several start-up companies including Revascular, Silk Road and Pro-med and serves on the scientific advisory boards of Abbott Vascular, Cardinal Health and Medtronic. In addition to his clinical and academic experience Dr. Schneider is also an inventor. He has licensed vascular devices to Cook Medical (tibial sheath) and developed a marker catheter for carotid interventions which was licensed to Angiodynamics. Dr. Schneider is a co-founder, of Cagent Vascular and was also a co-founder for Intact Vascular.

Robert Giasolli is a co-founder of Cagent Vascular serving as the Vice President of Research and Development and is the lead inventor of the Serranator Serration Balloon Catheter. Previously, Mr. Giasolli was a co-founder, inventor and VP of Research and Development of Intact Vascular. Robert was the chief designer for the Tack Endovascular System™. Mr. Giasolli has extensive experience in Intellectual Property strategy and claim development. Formerly, Mr. Giasolli served as a micro system technology executive with extensive experience in design and development of innovative devices. Mr. Giasolli has a strong scientific and business knowledge enabling quick and innovative approach to business development. He has served as a consultant for Smith & Nephew, TSMC, the US Army and Air Force, Sandia National Labs. He has built and outfitted two clean rooms and two metrology labs and has taught technicians and engineers proper use and control of the facilities. He has a BS in Physics from University of Texas at El Paso and an MS in Micro and Nano Manufacturing Systems Engineering from Louisiana Tech, Ruston, LA.

Peter Schneider is a Board Certified Vascular Surgeon who currently practices at Kaiser Permanente Clinic in Honolulu, Hawaii. He is a graduate of Johns Hopkins University School of Medicine. Dr. Schneider is an early adopter of endovascular techniques and has authored multiple scientific publications and books including Endovascular Skills (third edition textbook on endovascular techniques used by fellows and practitioners), Critical Limb Ischemia and Carotid Interventions. Dr. Schneider is also a frequent invited guest lecturer at national and international conferences. He is the Co-Principal Investigator (PI) of Medtronic’s IN.Pact US drug coated balloon trial. He also served as the PI in a carotid stent trial sponsored by WL Gore. Dr. Schneider is an advisor to several start-up companies including Revascular, Silk Road and Pro-med and serves on the scientific advisory boards of Abbott Vascular, Cardinal Health and Medtronic. In addition to his clinical and academic experience Dr. Schneider is also an inventor. He has licensed vascular devices to Cook Medical (tibial sheath) and developed a marker catheter for carotid interventions which was licensed to Angiodynamics. Dr. Schneider is a co-founder, of Cagent Vascular and was also a co-founder for Intact Vascular.

Bruce Shook is a medical device executive with more than 30 years of industry experience, including multiple early stage ventures focused on opportunities in cardiac surgery, cardiology, neurosurgery, psychiatry and vascular disease. He serves as Director, President and CEO for both Intact Vascular and Vesper Medical. Intact Vascular is a privately held medical technology company that develops and commercializes vascular scaffolding technology for the treatment of peripheral arterial disease. The company is currently marketing the Tack Endovascular System® in the U.S. and Europe. Vesper Medical was spun out of Intact Vascular in late 2016 and is developing a novel family of venous stents designed to treat deep venous disease.

Prior to Intact Vascular and Vesper Medical, Mr. Shook was co-founder, Director, President and CEO of Neuronetics, Inc., [NASDAQ: STIM] a publicly traded device company that markets a non-invasive brain stimulation technology for the treatment of depression.

Previously, Mr. Shook was co-founder, Director, President and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders, and President of Abiomed [NASDAQ: ABMD], where he obtained PMA approval for the first FDA-approved ventricular assist device. Mr. Shook also developed cardiac pacing and anti-arrhythmia products at Cordis Corporation.

Mr. Shook holds advanced degrees in Biomedical Engineering and Business Administration from Columbia University and the MIT Sloan School of Management, respectively. He earned a B.S. degree in Chemical Engineering from Penn State University. Mr. Shook currently serves on the Board of Directors at Neuronetics, Venarum Medical, the Penn State Research Foundation (Vice Chairman) and Life Sciences Pennsylvania (Medical Technology Committee Chairman). He previously served on the Board of Directors at Surgiquest, Respicardia and CoTherix.

Peter Schneider is a Board Certified Vascular Surgeon who currently practices at Kaiser Permanente Clinic in Honolulu, Hawaii. He is a graduate of Johns Hopkins University School of Medicine. Dr. Schneider is an early adopter of endovascular techniques and has authored multiple scientific publications and books including Endovascular Skills (third edition textbook on endovascular techniques used by fellows and practitioners), Critical Limb Ischemia and Carotid Interventions. Dr. Schneider is also a frequent invited guest lecturer at national and international conferences. He is the Co-Principal Investigator (PI) of Medtronic’s IN.Pact US drug coated balloon trial. He also served as the PI in a carotid stent trial sponsored by WL Gore. Dr. Schneider is an advisor to several start-up companies including Revascular, Silk Road and Pro-med and serves on the scientific advisory boards of Abbott Vascular, Cardinal Health and Medtronic. In addition to his clinical and academic experience Dr. Schneider is also an inventor. He has licensed vascular devices to Cook Medical (tibial sheath) and developed a marker catheter for carotid interventions which was licensed to Angiodynamics. Dr. Schneider is a co-founder, of Cagent Vascular and was also a co-founder for Intact Vascular.